Milestone Pharmaceuticals Inc.
MIST· Nasdaq
Released May 14, 2020, before the open
10-Q filed May 14, 2020, 44 days after period end · 0001558370-20-006548
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|
| Net Income | -$16.34M | -$10.45M | -$4.18M |
| EPS Diluted | -$0.67 | -$17.32 | -$15.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 14, 2020 · 44 d after period end